Hanna Y Irie

Hanna Y Irie, MD, PhD

  • ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
  • ASSISTANT PROFESSOR | Oncological Sciences

Specialties:

Oncology, Hematology-Oncology

Research Topics:

Anti-Tumor Therapy, Cancer, Cell Biology, Cell Transformation, Growth Factors and Receptors, Protein Kinases

I am a medical oncologist specializing in the care of patients with breast cancer. As a physician-scientist, I also lead a research laboratory that is focused on developing targeted therapies tailored for specific breast cancer subtypes and for individual patients. I have a particular interest in better understanding triple negative breast cancers, with the goal of integrating genetic analysis to the development of improved treatments for our patients.

I am co-PI of the Breast Tumor Biospecimen Repository, which is a bank of patient breast tumors; analysis of these tumors will provide insights into the genetic changes that determine sensitivity to specific targeted therapies for breast cancer. I am also co-PI of a study investigating the use of patient-derived xenograft models as a model for chemotherapy treatment sensitivity for patients with triple negative breast cancers; if successful, these models may be used in the future to help us better tailor treatments for individual patients. My research laboratory has identified several new candidate therapeutic targets for Her2+ and triple negative breast cancers resistant to current treatments, and we are working to translate our findings to clinical studies and trials.

I am a member of the American Society of Clinical Oncology and the American Association for Cancer Research.

Lab: http://www.mssm.edu/research/labs/irie-laboratory

 

 

Certifications

Medical Oncology

Clinical Focus


Education

MD/PHD, Harvard Medical School

BA, Harvard University

Clinical Fellow, Dana-Farber Cancer Institute

Instructor, Dana-Farber Cancer Institute/Harvard Medical School

Intern/Resident, Massachusetts General Hospital

MD, Harvard Medical School

PhD, Harvard Medical School

Research Fellow, Harvard Medical School

Residency, Internal Medicine, Massachusetts General Hospital

Fellowship, Hematology/Oncology, Dana Farber Cancer Institute